Search
Exelixis Inc
EXELAdd to Watchlist
57.430USD
-0.900-1.54%
Close 09-10 16:00（ET）
14.30BMarket Cap
18.39P/E TTM
After-hours (ET)0.000USD0.000
After-hours (ET)Exelixis Inc (EXEL) Stock Price Target & Forecast
Analyst Rating
Based on 20 analysts giving stock ratings to Exelixis Inc in the past month.
Hold
2 Strong Buy
5 Buy
12 Hold
1 Sell
0 Strong Sell
Target Price
53.718USD-8.97%
EXEL Analyst Recommendation Trends
In the current month, EXEL has received 5 Buy Ratings, 12 Hold Ratings, and 1 Sell Ratings. EXEL average Analyst price target in the last month is 53.718.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
3
4
4
4
4
4
5
5
5
6
6
6
6
6
12
12
10
9
9
10
10
10
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
20
20
19
20
20
21
21
21
EXEL Analyst Rating for Peer Comparison
Updated: Sep 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, EXEL EPS is projected to reach 0.828 in FY2026Q3, following reported EPS of 0.845 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.81
0.70
0.79
0.83
0.85
Actual
0.92
0.81
0.85
--
--
Surprise
+13.86%
+15.79%
+7.57%
--
--
FAQs
What is Exelixis Inc's expected revenue for the next quarter?
Exelixis Inc's expected revenue is 650.38M.
What is Exelixis Inc's price target?
Analysts forecast that Exelixis Inc's price target is USD 45.50, with the highest forecast at USD 60.00 and the lowest forecast at USD 30.00.
How have Exelixis IncEXEL's recent earnings per share performed?
The market expectation was USD 0.85, while Exelixis IncEXEL's earnings per share (EPS) for the previous quarter was USD 0.81. EPS for the next quarter is expected at USD 0.83.
What is the analyst rating for Exelixis Inc?
Based on the ratings of Exelixis Inc's stock from 20 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.